Please login to the form below

Not currently logged in


This page shows the latest oseltamivir news and features for those working in and with pharma, biotech and healthcare.

Roche’s influenza medicine approved by EC for children

Roche’s influenza medicine approved by EC for children

compared with oseltamivir. ... Time to alleviation of influenza signs and symptoms were comparable between Xofluza and oseltamivir, Roche reported, at 138 hours and 150 hours, respectively.

Latest news

More from news
Approximately 0 fully matching, plus 38 partially matching documents found.

Subscribe to our email news alerts


Add my company

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

Actinic keratosis – a common skin condition that can lead to skin cancer
PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
Man vs microbe: the fight against antimicrobial resistance
How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...